经皮机械循环支持与院外心脏骤停复苏后患者生存率:来自CARES监测组的研究
该研究通过概率链接将2014-2017年密歇根州CARES登记与住院患者数据库匹配,纳入3790例院外心脏骤停病例,其中1131例(29.8%)存活出院。机械循环支持使用较少,包括IABP 183例和Impella 50例。单因素分析中IABP(OR=2.16)和MCS(OR=2.07)与生存改善相关,但多因素模型校正后MCS与生存无独立关联(ORadj=0.95)。在725例心源性休克亚组中,单因素分析MCS与生存改善相关(OR=1.84),多因素校正后无统计学意义(ORadj=1.14)。
要点
- 单因素分析显示IABP使用与出院生存改善相关(OR=2.16, 95%CI 1.59-2.93),但多因素校正后MCS整体无独立关联(ORadj=0.95, 95%CI 0.69-1.31)。
- 心源性休克亚组(N=725)中,MCS单因素分析显示生存改善(OR=1.84, 95%CI 1.24-2.73),但多因素校正后无统计学意义(ORadj=1.14, 95%CI 0.74-1.77)。
- Impella使用与生存的关联接近统计学意义(OR=1.72, 95%CI 0.96-3.06),但样本量小(n=50)。
- 该研究为观察性登记链接分析,不能证明MCS与生存的因果关系,临床决策需谨慎。
适用人群与场景
- 2014-2017年密歇根州院外心脏骤停后复苏并存活至入院的患者,数据来自CARES登记与密歇根住院患者数据库的概率链接匹配。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:回顾性观察性研究,通过概率链接匹配CARES登记与密歇根住院患者数据库,纳入3790例院外心脏骤停病例,来自密歇根州。
- 主要终点为出院生存率:1131例(29.8%)存活出院;MCS使用包括IABP(n=183)和Impella(n=50)。
- 单因素分析:IABP与生存改善相关(未校正OR=2.16, 95%CI 1.59-2.93);Impella接近显著性(OR=1.72, 95%CI 0.96-3.06);MCS整体与生存改善相关(未校正OR=2.07, 95%CI 1.55-2.77)。
- 多因素模型校正后,MCS使用与生存无独立关联(ORadj=0.95, 95%CI 0.69-1.31)。
- 心源性休克亚组(N=725):单因素分析MCS与生存改善相关(未校正OR=1.84, 95%CI 1.24-2.73),多因素校正后无统计学意义(ORadj=1.14, 95%CI 0.74-1.77)。
证据类型、等级与局限
- 证据类型:回顾性观察性登记链接研究。
- 局限:观察性设计不能排除混杂;MCS使用率低(IABP n=183,Impella n=50),样本量有限;原文未报告证据等级或推荐强度。
对床旁实践的改变
- 该研究提示,在院外心脏骤停复苏后患者中,不应仅凭单因素关联常规使用MCS;校正混杂因素后MCS与生存无独立关联,需结合个体情况谨慎决策。
- 对于心源性休克亚组,单因素分析显示MCS与生存改善相关但多因素校正后无统计学意义,不能作为常规推荐依据。
- 常见陷阱:单因素分析中的生存改善可能由选择偏倚或混杂因素导致,不能直接推断因果。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Maintenance of cardiac function is required for successful outcome after out-of-hospital cardiac arrest (OHCA). Cardiac function can be augmented using a mechanical circulatory support (MCS) device, most commonly an intra-aortic balloon pump (IABP) or Impella®.
OBJECTIVE: Our objective is to assess whether the use of a MCS is associated with improved survival in patients resuscitated from OHCA in Michigan.
METHODS: We matched cardiac arrest cases during 2014-2017 from the Cardiac Arrest Registry to Enhance Survival (CARES) in Michigan and the Michigan Inpatient Database (MIDB) using probabilistic linkage. Multilevel logistic regression tested the association between MCS and the primary outcome of survival to hospital discharge.
RESULTS: A total of 3790 CARES cases were matched with the MIDB and 1131 (29.8%) survived to hospital discharge. A small number were treated with MCS, an IABP (n = 183) or Impella® (n = 50). IABP use was associated with an improved outcome (unadjusted OR = 2.16, 95%CI [1.59, 2.93]), while use of Impella® approached significance (OR = 1.72, 95% CI [0.96, 3.06]). Use of MCS was associated with improved outcome (unadjusted OR = 2.07, 95% CI [1.55, 2.77]). In a multivariable model, MCS use was no longer independently associated with improved outcome (ORadj = 0.95, 95% CI [0.69, 1.31]). In the subset of subjects with cardiogenic shock (N = 725), MCS was associated with improved survival in univariate (unadjusted OR = 1.84, 95% CI [1.24, 2.73]) but not multi-variable modeling (ORadj = 1.14, 95% CI [0.74, 1.77]).
CONCLUSION: Use of MCS was infrequent in patients resuscitated from OHCA and was not independently associated with improvement in post arrest survival after adjusting for covariates.
参考来源
- Tram J, Pressman A, Chen NW, et al. Percutaneous mechanical circulatory support and survival in patients resuscitated from Out of Hospital cardiac arrest: A study from the CARES surveillance group. Resuscitation. 2020. PMID: 33253768. doi:10.1016/j.resuscitation.2020.10.046
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。